MDXG

Mimedx Group Inc

3.97

Oct 29 • 3:59 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Small NASD

Today, 12:47 AMMiMedx returns to profitability on Surgical strength as Wound Care reset drags revenue

Peers: BSEM ORGO VCEL MDWD HUMA SMTI RCEL CNXU BVS CLGN

| Held by: VTI IWM AVUV XBI VXF IWN VTWO DFAS DFAT SCHA

Scroll to Statements

Index	RUT
Market Cap	579.32M
Enterprise Value	458.53M
Income	-19.19M
Sales	303.73M
Book/sh	1.45
Cash/sh	0.83
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	808
IPO	Aug 22, 2007

P/E	-
Forward P/E	52.24
PEG	-
P/S	1.91
P/B	2.74
P/C	4.80
P/FCF	30.52
EV/EBITDA	-
EV/Sales	1.51
Quick Ratio	3.84
Current Ratio	4.35
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.13
EPS next Y	0.08
EPS next Q	0.02
EPS this Y	-128.91%
EPS next Y	182.16%
EPS next 5Y	-17.96%
EPS past 3/5Y	- -
Sales past 3/5Y	16.05% 11.02%
EPS Y/Y TTM	-147.20%
Sales Y/Y TTM	-22.80%
EPS Q/Q	-153.17%
Sales Q/Q	-45.23%
Earnings	Oct 28 AMC
EPS/Sales Surpr.	-20100.00% -9.16%

Insider Own	21.58%
Insider Trans	0.00%
Inst Own	57.90%
Inst Trans	-0.27%
ROA	-6.58%
ROE	-8.53%
ROIC	-9.09%
Gross Margin	76.95%
Oper. Margin	-8.28%
Profit Margin	-6.32%
SMA20	-8.58%
SMA50	-11.68%
SMA200	-7.26%
Trades

Shs Outstand	145.93M
Shs Float	114.31M
Short Float	8.10%
Short Ratio	6.73
Short Interest	9.26M
52W High	7.97 -50.19%
52W Low	3.03 31.24%
Volatility	4.79% 4.83%
ATR (14)	0.21
RSI (14)	35.44
Beta	1.15
Rel Volume	0.00
Avg Volume	1.38M
Volume	0

Perf Week	1.02%
Perf Month	-14.81%
Perf Quarter	-3.87%
Perf Half Y	18.15%
Perf YTD	-41.36%
Perf Year	-44.78%
Perf 3Y	-35.45%
Perf 5Y	-42.04%
Perf 10Y	-54.78%
Recom	1.00
Target Price	7.00
Prev Close	3.97
Price	3.97
Change %	0.00%

Consensus

Strong Buy

Avg. Price Target

$7.00

Implied Upside

+76.3%

Analysts7incl. previous ratings

Rating Distribution7 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Feb 23, 2026	Initiated	CCitizens	Mkt Outperform	$10	+151.9%
Jul 02, 2024	Initiated	CCantor Fitzgerald	Overweight	$11	+177.1%
Mar 07, 2024	Initiated	LLake Street	Buy	$12	+202.3%
Oct 27, 2023	Initiated	CCraig Hallum	Buy	$12	+202.3%
Oct 13, 2022	Initiated	MMizuho	Buy	$7	+76.3%
Jul 26, 2021	Initiated	NNorthland Capital	Outperform	$23	+479.3%
Mar 19, 2021	Initiated	HH.C. Wainwright	Buy	$20	+403.8%

Oct-28-26 07:24PM	MiMedx Returns To Positive Adjusted EBITDA On Margin Rebound, But Another Revenue Guidance Cut And Slower Surgical Growth Cap The Recovery (Earnings Whispers)
04:56PM	MiMedx: Q3 Earnings Snapshot (Associated Press)
04:03PM	MIMEDX Announces Third Quarter 2026 Operating & Financial Results (GlobeNewswire)
04:01PM	MIMEDX Announces $25 Million Patent License Agreement (GlobeNewswire)
Oct-20-26 05:20PM	MiMedx Must Show Its Wound Care Rebound Outlasted A Strong June (Earnings Whispers) -11.58%
01:00PM	Loading…
Oct-16-26 01:00PM	MiMedx-Sanara Merger Faces Fresh Regulatory Obstacle SMTI Stock Falls Below This Key Support Level For The First Time In 4 Months (Stocktwits) -5.34%
Oct-14-26 04:01PM	MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026 (GlobeNewswire)
Sep-23-26 04:01PM	MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL Regulatory Classification Matter (GlobeNewswire)
Sep-08-26 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-30-26 01:03AM	MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ... (GuruFocus.com)
Jul-29-26 04:46PM	MiMedx: Q2 Earnings Snapshot (Associated Press)
04:07PM	MIMEDX Announces Second Quarter 2026 Operating & Financial Results (GlobeNewswire)
04:01PM	MIMEDX to Acquire Sanara MedTech (GlobeNewswire)
Jul-28-26 09:49AM	Earnings To Watch: MiMedx Group Inc (MDXG) Q2 2026 -- GF Value Sees 35% Upside (GuruFocus.com)
Jul-20-26 08:00AM	MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29 (GlobeNewswire)
09:00AM	Loading…
Jun-02-26 09:00AM	The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts (PR Newswire)
May-21-26 08:45AM	MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference (GlobeNewswire)
May-08-26 08:00AM	MIMEDX Announces Launch of G4Derm Plus (GlobeNewswire)
Apr-30-26 03:16AM	MiMedx Group Inc (MDXG) Q1 2026 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) +8.91%
Apr-29-26 04:55PM	MiMedx: Q1 Earnings Snapshot (Associated Press) -9.26%
04:01PM	MIMEDX Announces First Quarter 2026 Operating & Financial Results (GlobeNewswire)
Apr-28-26 09:26AM	MiMedx Group Inc (MDXG) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Apr-22-26 08:00AM	MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29 (GlobeNewswire)
Apr-16-26 08:00AM	MIMEDX Announces Restructuring and Cost Reduction Initiative (GlobeNewswire) -11.60%
Apr-02-26 09:15AM	MIMEDX to Sponsor Leading Advanced Wound Care Conferences (GlobeNewswire)
Mar-23-26 08:00AM	MIMEDX Announces Launch of CHORIOFIX (GlobeNewswire)
Mar-05-26 08:00AM	MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX Thyroid Shields (GlobeNewswire)
Mar-01-26 03:20AM	MiMedx Group (MDXG) Delivers Record Full Year Revenue (Insider Monkey)
Feb-26-26 12:07AM	MiMedx Group Q4 Earnings Call Highlights (MarketBeat) -6.44%
12:05AM	MiMedx Group Inc (MDXG) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
07:25PM	Loading…
Feb-25-26 07:25PM	MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:42PM	MiMedx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results (GlobeNewswire)
Feb-24-26 07:28AM	MiMedx Group Inc (MDXG) Q4 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Feb-17-26 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 (GlobeNewswire)
Feb-04-26 10:27AM	MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products (GlobeNewswire)
Feb-02-26 03:27PM	Craig-Hallum Adjusts MiMedx Group, Inc. (MDXG) Outlook on CMS Coverage Guidance (Insider Monkey)
08:00AM	MIMEDX Celebrates 15 Year Anniversary of EPIFIX and AMNIOFIX (GlobeNewswire)
Dec-22-25 09:43AM	MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel (GlobeNewswire)
Dec-19-25 09:00AM	MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion Processed Human Amniotic Membrane Allografts In Vitro (GlobeNewswire)
Nov-17-25 09:55AM	MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Nov-13-25 08:00AM	MIMEDX Provides Update on EPIEFFECT Randomized Controlled Trial (GlobeNewswire)
Nov-10-25 04:01PM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-03-25 09:15AM	MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule (GlobeNewswire)
Oct-31-25 09:55AM	Wall Street Analysts Predict a 64.86% Upside in MiMedx (MDXG): Here's What You Should Know (Zacks)
Oct-29-25 05:25PM	MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:23PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Record Revenue for Third Quarter 2025 (GlobeNewswire)
Oct-28-25 09:50AM	Earnings To Watch: MiMedx Group Inc (MDXG) Reports Q3 2025 Result (GuruFocus.com)
Oct-15-25 08:00AM	MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29 (GlobeNewswire)
Oct-06-25 09:28AM	MIMEDX Announces Launch of EPIXPRESS (GlobeNewswire)
Sep-03-25 08:00AM	MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall (GlobeNewswire)
Aug-29-25 05:11AM	MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy (Insider Monkey)
Aug-27-25 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-31-25 03:32AM	MiMedx Group Inc (MDXG) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) +10.28%
Jul-30-25 05:40PM	MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:50PM	MiMedx: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results (GlobeNewswire)
08:00AM	MIMEDX Announces Strategic Collaboration with Vaporox, Inc. (GlobeNewswire)
Jul-29-25 09:50AM	What To Expect From MiMedx Group Inc (MDXG) Q2 2025 Earnings (GuruFocus.com)
Jul-16-25 09:15AM	Northland sees key positive for MiMedx in CMS rule proposal (TipRanks) +6.00%
08:00AM	MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30 (GlobeNewswire)
Jul-15-25 09:15AM	MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026 (GlobeNewswire) -6.91%
Jul-14-25 05:22PM	MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending (Investing.com)
Jul-09-25 09:36AM	Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength? (Zacks)
May-27-25 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-14-25 06:00AM	Insiders Pour $1 Million Each into These 2 Strong Buy Stocks Heres Why You Might Want to Follow Their Lead (TipRanks)
May-06-25 08:00AM	MIMEDX to Present at the BofA Securities 2025 Healthcare Conference (GlobeNewswire)
May-05-25 08:30AM	MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS) (GlobeNewswire)
May-01-25 11:03AM	Q1 2025 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents) -8.14%
03:18AM	MiMedx Group Inc (MDXG) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
Apr-30-25 09:52PM	MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:15PM	MiMedx (MDXG) Q1 Earnings Match Estimates (Zacks)
04:19PM	MiMedx: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces First Quarter 2025 Operating and Financial Results (GlobeNewswire)
Apr-16-25 08:00AM	MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30 (GlobeNewswire)
Apr-10-25 04:01PM	MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences (GlobeNewswire)
Mar-31-25 05:45PM	BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Mar-20-25 01:58AM	Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength? (Zacks)
Feb-27-25 08:22AM	Q4 2024 MiMedx Group Inc Earnings Call (Thomson Reuters StreetEvents)
08:00AM	MIMEDX to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
02:22AM	MiMedx Group Inc (MDXG) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Feb-26-25 05:55PM	MiMedx (MDXG) Q4 Earnings Meet Estimates (Zacks)
05:04PM	MiMedx: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results (GlobeNewswire)
Feb-25-25 10:37AM	Earnings To Watch: MiMedx Group Inc (MDXG) Reports Q4 2024 Result (GuruFocus.com)
Feb-05-25 08:00AM	MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 (GlobeNewswire)
Dec-17-24 09:00AM	MIMEDX Files Patent Infringement Lawsuit Against Surgenex (GlobeNewswire)
Dec-04-24 08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-20-24 09:55AM	How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12% (Zacks)
Nov-14-24 09:15AM	MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs (GlobeNewswire) +23.56%
Nov-04-24 09:55AM	Can MiMedx (MDXG) Climb 77.92% to Reach the Level Wall Street Analysts Expect? (Zacks)
08:00AM	MIMEDX to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-31-24 05:00AM	MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong International Growth and New ... (GuruFocus.com) +20.39%
Oct-30-24 05:25PM	MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
04:26PM	MiMedx: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MIMEDX Announces Third Quarter 2024 Operating and Financial Results (GlobeNewswire)
Oct-14-24 08:00AM	MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 (GlobeNewswire)
Oct-09-24 03:36PM	MiMedx Group Inc (MDXG) Q2 2024 Earnings Call Highlights: Strong Sales Growth Amid Market Challenges (GuruFocus.com)
Oct-08-24 04:01PM	MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maersk-Moller Kimberly	Chief Commercial Officer	Mar 10 '26	Option Exercise	4.50	42,845	192,802	357,482	Mar 12 05:37 PM
Hulse William Frank IV	General Counsel and CAO	Mar 10 '26	Option Exercise	4.50	136,364	613,638	624,900	Mar 12 05:35 PM
DOUG RICE	Chief Financial Officer	Mar 10 '26	Option Exercise	4.50	243,000	1,093,500	508,678	Mar 12 05:34 PM
Maersk-Moller Kimberly	Chief Commercial Officer	Nov 06 '25	Sale	7.42	58,300	432,329	236,982	Nov 10 05:14 PM
Kimberly Ann Maersk-Moller	Officer	Nov 06 '25	Proposed Sale	7.33	68,587	502,743		Nov 06 04:14 PM

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

CEO & DirectorMr. Joseph H. Capper

Chief Financial OfficerMr. Douglas C. Rice CPA

General Counsel & Chief Administrative OfficerMr. William F. Hulse IV

Chief Commercial OfficerMs. Kimberly Maersk-Moller

SVP of R&D & Medical Affairs and Chief Scientific OfficerDr. John Harper Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDXG

Mimedx Group Inc

Upgrade your Finviz experience